Ledger.Open graph →
SEC Form D · Amendment · filed March 11, 2020

C16 Biosciences, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Shara Ticku · New York, NYExec · Director · PromoterHarold Mcnamara · New York, NYDirector · PromoterPeter Turner · New York, NYDirectorDavid Heller · New York, NYPromoterAndrew Leu · San Diego, CADirector · PromoterMarcelo Maisonnave De Oliveira · Grand Cayman, Cayman IslandsPromoterShara Ticku · New York, NYExec · Director · PromoterDavid North · Atlanta, GADirectorLloyd Ho · Menlo Park, CADirectorHunt D. Hanover · San Francisco, CAPromoterPaul Eisenstein · San Francisco, CAExec · Director · PromoterCarlos J. Gonzales-Cadenas · London, United KingdomDirector · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗